Skip to main content
logo
InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
1.330
-0.020 (-1.48%)
Oct 2, 2026, 4:00 PM EDT - Market closed

InMed Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
9742310
Market Cap Growth
66.95%76.38%65.68%-23.21%-68.01%-62.35%
Enterprise Value
720-4-65
Last Close Price
1.331.553.255.3118.53235.20

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
---0.520.758.85
PB Ratio
6.616.440.290.260.261.06
P/TBV Ratio
8.226.440.330.320.301.38

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
-----4.24

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Debt / Equity Ratio
--0.060.110.030.09
Net Debt / Equity Ratio
-2.08-2.08-0.75-0.61-0.71-0.60
Net Debt / EBITDA Ratio
0.230.231.220.711.050.41
Net Debt / FCF Ratio
0.260.261.240.811.150.35
Asset Turnover
---0.360.310.10
Inventory Turnover
---2.441.33-
Quick Ratio
1.141.145.863.534.611.90
Current Ratio
1.371.376.994.415.662.89
Return on Equity (ROE)
-156.77%-156.77%-76.77%-72.08%-75.09%-226.07%
Return on Assets (ROA)
-66.46%-66.46%-38.53%-39.22%-38.94%-75.28%
Return on Capital Employed (ROCE)
-920.50%-920.50%-61.50%-82.60%-69.20%-143.60%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-147.03%-181.52%-208.04%-324.14%-257.74%-192.96%
FCF Yield
-97.81%-124.91%-206.44%-295.41%-241.44%-162.08%
Buyback Yield / Dilution
-326.64%-326.64%-156.11%-211.26%-336.59%-108.64%
SEC Filings: 10-K · 10-Q